The jury's verdicts capped more than 37 hours of deliberations over a four-and-a-half days in the Dutchess County Courthouse, in Poughkeepsie.

Gilleo, 33, of Hopewell Junction, N.Y., also was convicted on five counts of armed robbery, two counts of conspiracy, one count of perjury and two counts of arson.

A co-defendant, 30-year-old Mark Serrano, was convicted last year on 31 first- and second-degree murder charges, in addition to arson, robbery, conspiracy and perjury charges.

Gilleo and Serrano were accused of going to the Morey home on Route 82 in Fishkill and robbing Manuel and Tina of cash and cocaine, killing all five members of the family and setting fire to their house and car in an attempt to cover up the crimes.

Carlos Kauffmann, 35, was one of five men accused of acting on behalf of Venezuela's anti-U.S. government in a case that touched off corruption allegations in Argentina and diplomatic tensions between the Washington, Caracas and Buenos Aires.

Kauffmann entered a guilty plea on Friday to a charge of conspiring to act as an agent of Venezuela without registering with the U.S. government and could face five years in prison. He agreed to cooperate with prosecutors, according to a plea agreement released by the U.S. Attorney's Office in Miami.

Ritchie and five members of his entourage were arrested October 21st on a misdemeanor charge of simple battery. The charges stem from a fight at a a metro-Atlanta Waffle House, where they had stopped following his performance at The Tabernacle.

Officials say a fight broke out after another customer recognized a woman in Kid Rock's party and exchanged words with her, prompting Ritchie to exchange words, too.

The dispute stems from several suits against Warner-Lambert over its diabetes drug Rezulin. Warner-Lambert is now owned by Pfizer. The Supreme Court split 4-4 in the case, with Chief Justice John Roberts not participating.

The users of the drug are relying on a Michigan law to allege that the pharmaceutical company engaged in fraud by misleading federal regulators to get the drug approved. The Michigan law shields pharmaceutical companies from product liability lawsuits, unless they committed fraud.

At issue in the case is whether that fraud exception, which allows lawsuits to proceed, is pre-empted by federal regulation of the pharmaceutical industry.

The 2nd U.S. Circuit Court of Appeals in New York ruled that the exception to the Michigan law was not pre-empted by federal regulations, enabling the plaintiffs to pursue the case.

Twenty-seven Michigan residents say they suffered personal injuries caused by Rezulin, a drug that federal regulators approved despite risks to the liver and cardiovascular system.